CNTA vs HPE · $6.15B cap vs P/E 20, rev $32.19B
Centessa Pharmaceuticals PLC ADR (CNTA) versus Hewlett Packard Enterprise Co (HPE) — a side-by-side from cached financials, not a winner call.
Centessa Pharmaceuticals PLC ADR (CNTA) is a biotechnology company listed on US.
Hewlett Packard Enterprise Co (HPE) is a communication equipment company listed on US.
Latest reported CNTA revenue for 2024-12-31 was $0. Net income was -$235.8M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. CNTA currently screens at market cap $6.15B.
Latest reported HPE revenue for 2026-07-31 was $32.19B. Net income was $2.62B. Revenue was up 61.1% from 2026-04-30 to 2026-07-31. HPE currently screens at market cap $27.19B and trailing P/E 19.9.
CNTA currently screens at market cap $6.15B. HPE currently screens at market cap $27.19B and trailing P/E 19.9.
Not investment advice. Open the CNTA and HPE stock pages for the full models.
Not investment advice.